Bosulif

Active Ingredient(s): Bosutinib
FDA Approved: * September 4, 2012
Pharm Company: * WYETH PHARMS INC
Category: Cancer

Bosutinib (rINN/USAN; codenamed SKI-606, marketed under the trade name Bosulif) is a small molecule BCR-ABL and src tyrosine kinase inhibitor used for the treatment of chronic myelogenous leukemia. Originally synthesized by Wyeth, it is being developed by Pfizer. Contents 1 Mechanism 2 Medical uses 3 Contraindications 4 Interactions 5 Notes 6 See also 7 References 8 External links Mechanism It is an ATP-competitive Bcr-Abl tyrosine-kinase inhibitor with an additional inhibitory effect... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
4 Discussions

Dosage List

Bosulif Pfizer;500
Bosulif 500 mg Oral Tablet
NDC: 0069-0136
Labeler:
Pfizer Laboratories Div Pfizer Inc
Bosulif 100 mg Oral Tablet
NDC: 0069-0135
Labeler:
Pfizer Laboratories Div Pfizer Inc
Bosulif 400 mg Oral Tablet, Film Coated
NDC: 0069-0193
Labeler:
Pfizer Laboratories Div Pfizer Inc
Bosulif 50 mg Oral Capsule
NDC: 0069-0504
Labeler:
Pfizer Laboratories Div Pfizer Inc
Bosulif 100 mg Oral Capsule
NDC: 0069-1014
Labeler:
Pfizer Laboratories Div Pfizer Inc
Bosulif 100 mg Oral Tablet, Film Coated
NDC: 63539-117
Labeler:
U.S. Pharmaceuticals
Bosulif 400 mg Oral Tablet, Film Coated
NDC: 63539-193
Labeler:
U.S. Pharmaceuticals

Popular Topics

chest pain while taking bosulif

I have been taking bosulif for a little over a year now. I first started with 300 mg with very few side effects. About 1...

1 REPLY
Patient assistance income guidelines for Bosulif

Does anyone know the income guidelines for the patient assistance program for Bosulif? ## @Jake, Interestingly enough, P...

1 REPLY